APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemical API CDMO

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chemical API CDMO Market Analysis and Forecast 2026-2032

4 January 2026208 pages

Choose your research edition.

Industry ResearchChemical API CDMO Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemical API CDMO Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Chemical API CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemical API CDMO Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemical API CDMO Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Chemical API CDMO market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Chemical API CDMO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chemical API CDMO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chemical API CDMO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chemical API CDMO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Chemical API CDMO include Flamma Group, HAS Healthcare, Asymchem, Recipharm, Pierre Fabre, Pfizer CentreOne, Axplora, Lonza and MAI CDMO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Chemical API CDMO, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chemical API CDMO, also provides the revenue of main regions and countries. Of the upcoming market potential for Chemical API CDMO, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chemical API CDMO revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chemical API CDMO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Chemical API CDMO revenue, projected growth trends, production technology, application and end-user industry.

Chemical API CDMO Segment by Company

Flamma Group

HAS Healthcare

Asymchem

Recipharm

Pierre Fabre

Pfizer CentreOne

Axplora

Lonza

MAI CDMO

BioVectra

Curia

AGC Pharma Chemicals

Asymchem

Olon Group

Evonik Health Care

Teva Active Pharmaceutical Ingredients

Chemical API CDMO Segment by Type

Small Molecule CDMO

Macromolecule CDMO

Cell Gene Therapy (CGT) CDMO

Chemical API CDMO Segment by Application

Pharmaceutical and Biotechnology Companies

Research and Academic Institutions

Hospital

Others

Chemical API CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemical API CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemical API CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemical API CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Chemical API CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Chemical API CDMO company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemical API CDMO revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chemical API CDMO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Small Molecule CDMO Major Player Table 3. Macromolecule CDMO Major Player Table 4. Cell Gene Therapy (CGT) CDMO Major Player Table 5. Global Chemical API CDMO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical and Biotechnology Companies Major Player Table 7. Research and Academic Institutions Major Player Table 8. Hospital Major Player Table 9. Others Major Player Table 10. Chemical API CDMO Industry Trends Table 11. Chemical API CDMO Industry Drivers Table 12. Chemical API CDMO Industry Opportunities and Challenges Table 13. Chemical API CDMO Industry Restraints Table 14. Global Chemical API CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Chemical API CDMO Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Chemical API CDMO Market Share by Region (2021-2026) Table 17. Global Chemical API CDMO Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Chemical API CDMO Market Share by Region (2027-2032) Table 19. Global Chemical API CDMO Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Chemical API CDMO Revenue Market Share by Players (2021-2026) Table 21. Global Chemical API CDMO Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Chemical API CDMO Key Players Headquarters & Area Served Table 23. Global Chemical API CDMO Players, Product Type & Application Table 24. Global Chemical API CDMO Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Chemical API CDMO by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Chemical API CDMO Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Chemical API CDMO Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Chemical API CDMO Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Chemical API CDMO Revenue Market Share by Type (2021-2026) Table 31. Global Chemical API CDMO Revenue Market Share by Type (2027-2032) Table 32. Global Chemical API CDMO Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Chemical API CDMO Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Chemical API CDMO Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Chemical API CDMO Revenue Market Share by Application (2021-2026) Table 36. Global Chemical API CDMO Revenue Market Share by Application (2027-2032) Table 37. Flamma Group Company Information Table 38. Flamma Group Business Overview Table 39. Flamma Group Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Flamma Group Chemical API CDMO Product Portfolio Table 41. Flamma Group Recent Development Table 42. HAS Healthcare Company Information Table 43. HAS Healthcare Business Overview Table 44. HAS Healthcare Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. HAS Healthcare Chemical API CDMO Product Portfolio Table 46. HAS Healthcare Recent Development Table 47. Asymchem Company Information Table 48. Asymchem Business Overview Table 49. Asymchem Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Asymchem Chemical API CDMO Product Portfolio Table 51. Asymchem Recent Development Table 52. Recipharm Company Information Table 53. Recipharm Business Overview Table 54. Recipharm Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Recipharm Chemical API CDMO Product Portfolio Table 56. Recipharm Recent Development Table 57. Pierre Fabre Company Information Table 58. Pierre Fabre Business Overview Table 59. Pierre Fabre Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Pierre Fabre Chemical API CDMO Product Portfolio Table 61. Pierre Fabre Recent Development Table 62. Pfizer CentreOne Company Information Table 63. Pfizer CentreOne Business Overview Table 64. Pfizer CentreOne Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Pfizer CentreOne Chemical API CDMO Product Portfolio Table 66. Pfizer CentreOne Recent Development Table 67. Axplora Company Information Table 68. Axplora Business Overview Table 69. Axplora Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Axplora Chemical API CDMO Product Portfolio Table 71. Axplora Recent Development Table 72. Lonza Company Information Table 73. Lonza Business Overview Table 74. Lonza Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Lonza Chemical API CDMO Product Portfolio Table 76. Lonza Recent Development Table 77. MAI CDMO Company Information Table 78. MAI CDMO Business Overview Table 79. MAI CDMO Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. MAI CDMO Chemical API CDMO Product Portfolio Table 81. MAI CDMO Recent Development Table 82. BioVectra Company Information Table 83. BioVectra Business Overview Table 84. BioVectra Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. BioVectra Chemical API CDMO Product Portfolio Table 86. BioVectra Recent Development Table 87. Curia Company Information Table 88. Curia Business Overview Table 89. Curia Chemical API CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Curia Chemical API CDMO Product Portfolio Table 91. Curia Recent Development Table 92. AGC Pharma Chemicals Company Information Table 93. AGC Pharma Chemicals Business Overview Table 94. AGC Pharma Chemicals Chemical API CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. AGC Pharma Chemicals Chemical API CDMO Product Portfolio Table 96. AGC Pharma Chemicals Recent Development Table 97. Asymchem Company Information Table 98. Asymchem Business Overview Table 99. Asymchem Chemical API CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Asymchem Chemical API CDMO Product Portfolio Table 101. Asymchem Recent Development Table 102. Olon Group Company Information Table 103. Olon Group Business Overview Table 104. Olon Group Chemical API CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Olon Group Chemical API CDMO Product Portfolio Table 106. Olon Group Recent Development Table 107. Evonik Health Care Company Information Table 108. Evonik Health Care Business Overview Table 109. Evonik Health Care Chemical API CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Evonik Health Care Chemical API CDMO Product Portfolio Table 111. Evonik Health Care Recent Development Table 112. Teva Active Pharmaceutical Ingredients Company Information Table 113. Teva Active Pharmaceutical Ingredients Business Overview Table 114. Teva Active Pharmaceutical Ingredients Chemical API CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Teva Active Pharmaceutical Ingredients Chemical API CDMO Product Portfolio Table 116. Teva Active Pharmaceutical Ingredients Recent Development Table 117. North America Chemical API CDMO Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Chemical API CDMO Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Chemical API CDMO Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Chemical API CDMO Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Chemical API CDMO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Chemical API CDMO Revenue by Country (2021-2026) & (US$ Million) Table 123. North America Chemical API CDMO Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe Chemical API CDMO Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Chemical API CDMO Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Chemical API CDMO Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Chemical API CDMO Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Chemical API CDMO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Chemical API CDMO Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe Chemical API CDMO Revenue by Country (US$ Million) & (2027-2032) Table 131. China Chemical API CDMO Revenue by Type (2021-2026) & (US$ Million) Table 132. China Chemical API CDMO Revenue by Type (2027-2032) & (US$ Million) Table 133. China Chemical API CDMO Revenue by Application (2021-2026) & (US$ Million) Table 134. China Chemical API CDMO Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Chemical API CDMO Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Chemical API CDMO Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Chemical API CDMO Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Chemical API CDMO Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Chemical API CDMO Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Chemical API CDMO Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia Chemical API CDMO Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA Chemical API CDMO Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA Chemical API CDMO Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA Chemical API CDMO Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA Chemical API CDMO Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA Chemical API CDMO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA Chemical API CDMO Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA Chemical API CDMO Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Chemical API CDMO Image Figure 2. Global Chemical API CDMO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chemical API CDMO Market Size Share 2021 VS 2025 VS 2032 Figure 4. Small Molecule CDMO Image Figure 5. Macromolecule CDMO Image Figure 6. Cell Gene Therapy (CGT) CDMO Image Figure 7. Global Chemical API CDMO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Chemical API CDMO Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical and Biotechnology Companies Image Figure 10. Research and Academic Institutions Image Figure 11. Hospital Image Figure 12. Others Image Figure 13. Global Chemical API CDMO Market Size (US$ Million) & (2021-2032) Figure 14. Global Chemical API CDMO Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Chemical API CDMO Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Chemical API CDMO Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Chemical API CDMO Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Chemical API CDMO Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Chemical API CDMO Revenue Market Share by Type (2021-2032) Figure 21. Global Chemical API CDMO Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Chemical API CDMO Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Chemical API CDMO Revenue Market Share by Application (2021-2032) Figure 24. North America Chemical API CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Chemical API CDMO Revenue Share by Type (2021-2032) Figure 26. North America Chemical API CDMO Revenue Share by Application (2021-2032) Figure 27. North America Chemical API CDMO Revenue Share by Country (2021-2032) Figure 28. United States Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Chemical API CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Chemical API CDMO Revenue Share by Type (2021-2032) Figure 33. Europe Chemical API CDMO Revenue Share by Application (2021-2032) Figure 34. Europe Chemical API CDMO Revenue Share by Country (2021-2032) Figure 35. Germany Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Chemical API CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Chemical API CDMO Revenue Share by Type (2021-2032) Figure 45. China Chemical API CDMO Revenue Share by Application (2021-2032) Figure 46. Asia Chemical API CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Chemical API CDMO Revenue Share by Type (2021-2032) Figure 48. Asia Chemical API CDMO Revenue Share by Application (2021-2032) Figure 49. Asia Chemical API CDMO Revenue Share by Region (2021-2032) Figure 50. Japan Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Chemical API CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Chemical API CDMO Revenue Share by Type (2021-2032) Figure 58. SAMEA Chemical API CDMO Revenue Share by Application (2021-2032) Figure 59. SAMEA Chemical API CDMO Revenue Share by Country (2021-2032) Figure 60. Brazil Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Chemical API CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule CDMO
  • Macromolecule CDMO
  • Cell Gene Therapy (CGT) CDMO
Applications
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutions
  • Hospital
  • Others
Companies covered
  • Flamma Group
  • HAS Healthcare
  • Asymchem
  • Recipharm
  • Pierre Fabre
  • Pfizer CentreOne
  • Axplora
  • Lonza
  • MAI CDMO
  • BioVectra
  • Curia
  • AGC Pharma Chemicals
  • Asymchem
  • Olon Group
  • Evonik Health Care
  • Teva Active Pharmaceutical Ingredients

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chemical API CDMO Market by Type
  3. 1.2.1 Global Chemical API CDMO Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Small Molecule CDMO
  5. 1.2.3 Macromolecule CDMO
  6. 1.2.4 Cell Gene Therapy (CGT) CDMO
  7. 1.3 Chemical API CDMO Market by Application
  8. 1.3.1 Global Chemical API CDMO Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical and Biotechnology Companies
  10. 1.3.3 Research and Academic Institutions
  11. 1.3.4 Hospital
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Chemical API CDMO Market Dynamics
  1. 2.1 Chemical API CDMO Industry Trends
  2. 2.2 Chemical API CDMO Industry Drivers
  3. 2.3 Chemical API CDMO Industry Opportunities and Challenges
  4. 2.4 Chemical API CDMO Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Chemical API CDMO Market Perspective (2021-2032)
  2. 3.2 Global Chemical API CDMO Growth Trends by Region
  3. 3.2.1 Global Chemical API CDMO Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chemical API CDMO Market Size by Region (2021-2026)
  5. 3.2.3 Global Chemical API CDMO Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Chemical API CDMO Revenue by Players
  2. 4.1.1 Global Chemical API CDMO Revenue by Players (2021-2026)
  3. 4.1.2 Global Chemical API CDMO Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Chemical API CDMO Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chemical API CDMO Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Chemical API CDMO Key Players Headquarters & Area Served
  7. 4.4 Global Chemical API CDMO Players, Product Type & Application
  8. 4.5 Global Chemical API CDMO Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Chemical API CDMO Market CR5 and HHI
  11. 4.6.3 2025 Chemical API CDMO Tier 1, Tier 2, and Tier 3
5 Chemical API CDMO Market Size by Type
  1. 5.1 Global Chemical API CDMO Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Chemical API CDMO Revenue by Type (2021-2032)
  3. 5.3 Global Chemical API CDMO Revenue Market Share by Type (2021-2032)
6 Chemical API CDMO Market Size by Application
  1. 6.1 Global Chemical API CDMO Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Chemical API CDMO Revenue by Application (2021-2032)
  3. 6.3 Global Chemical API CDMO Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Flamma Group
  2. 7.1.1 Flamma Group Company Information
  3. 7.1.2 Flamma Group Business Overview
  4. 7.1.3 Flamma Group Chemical API CDMO Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Flamma Group Chemical API CDMO Product Portfolio
  6. 7.1.5 Flamma Group Recent Developments
  7. 7.2 HAS Healthcare
  8. 7.2.1 HAS Healthcare Company Information
  9. 7.2.2 HAS Healthcare Business Overview
  10. 7.2.3 HAS Healthcare Chemical API CDMO Revenue and Gross Margin (2021-2026)
  11. 7.2.4 HAS Healthcare Chemical API CDMO Product Portfolio
  12. 7.2.5 HAS Healthcare Recent Developments
  13. 7.3 Asymchem
  14. 7.3.1 Asymchem Company Information
  15. 7.3.2 Asymchem Business Overview
  16. 7.3.3 Asymchem Chemical API CDMO Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Asymchem Chemical API CDMO Product Portfolio
  18. 7.3.5 Asymchem Recent Developments
  19. 7.4 Recipharm
  20. 7.4.1 Recipharm Company Information
  21. 7.4.2 Recipharm Business Overview
  22. 7.4.3 Recipharm Chemical API CDMO Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Recipharm Chemical API CDMO Product Portfolio
  24. 7.4.5 Recipharm Recent Developments
  25. 7.5 Pierre Fabre
  26. 7.5.1 Pierre Fabre Company Information
  27. 7.5.2 Pierre Fabre Business Overview
  28. 7.5.3 Pierre Fabre Chemical API CDMO Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pierre Fabre Chemical API CDMO Product Portfolio
  30. 7.5.5 Pierre Fabre Recent Developments
  31. 7.6 Pfizer CentreOne
  32. 7.6.1 Pfizer CentreOne Company Information
  33. 7.6.2 Pfizer CentreOne Business Overview
  34. 7.6.3 Pfizer CentreOne Chemical API CDMO Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer CentreOne Chemical API CDMO Product Portfolio
  36. 7.6.5 Pfizer CentreOne Recent Developments
  37. 7.7 Axplora
  38. 7.7.1 Axplora Company Information
  39. 7.7.2 Axplora Business Overview
  40. 7.7.3 Axplora Chemical API CDMO Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Axplora Chemical API CDMO Product Portfolio
  42. 7.7.5 Axplora Recent Developments
  43. 7.8 Lonza
  44. 7.8.1 Lonza Company Information
  45. 7.8.2 Lonza Business Overview
  46. 7.8.3 Lonza Chemical API CDMO Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Lonza Chemical API CDMO Product Portfolio
  48. 7.8.5 Lonza Recent Developments
  49. 7.9 MAI CDMO
  50. 7.9.1 MAI CDMO Company Information
  51. 7.9.2 MAI CDMO Business Overview
  52. 7.9.3 MAI CDMO Chemical API CDMO Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MAI CDMO Chemical API CDMO Product Portfolio
  54. 7.9.5 MAI CDMO Recent Developments
  55. 7.10 BioVectra
  56. 7.10.1 BioVectra Company Information
  57. 7.10.2 BioVectra Business Overview
  58. 7.10.3 BioVectra Chemical API CDMO Revenue and Gross Margin (2021-2026)
  59. 7.10.4 BioVectra Chemical API CDMO Product Portfolio
  60. 7.10.5 BioVectra Recent Developments
  61. 7.11 Curia
  62. 7.11.1 Curia Company Information
  63. 7.11.2 Curia Business Overview
  64. 7.11.3 Curia Chemical API CDMO Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Curia Chemical API CDMO Product Portfolio
  66. 7.11.5 Curia Recent Developments
  67. 7.12 AGC Pharma Chemicals
  68. 7.12.1 AGC Pharma Chemicals Company Information
  69. 7.12.2 AGC Pharma Chemicals Business Overview
  70. 7.12.3 AGC Pharma Chemicals Chemical API CDMO Revenue and Gross Margin (2021-2026)
  71. 7.12.4 AGC Pharma Chemicals Chemical API CDMO Product Portfolio
  72. 7.12.5 AGC Pharma Chemicals Recent Developments
  73. 7.13 Asymchem
  74. 7.13.1 Asymchem Company Information
  75. 7.13.2 Asymchem Business Overview
  76. 7.13.3 Asymchem Chemical API CDMO Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Asymchem Chemical API CDMO Product Portfolio
  78. 7.13.5 Asymchem Recent Developments
  79. 7.14 Olon Group
  80. 7.14.1 Olon Group Company Information
  81. 7.14.2 Olon Group Business Overview
  82. 7.14.3 Olon Group Chemical API CDMO Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Olon Group Chemical API CDMO Product Portfolio
  84. 7.14.5 Olon Group Recent Developments
  85. 7.15 Evonik Health Care
  86. 7.15.1 Evonik Health Care Company Information
  87. 7.15.2 Evonik Health Care Business Overview
  88. 7.15.3 Evonik Health Care Chemical API CDMO Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Evonik Health Care Chemical API CDMO Product Portfolio
  90. 7.15.5 Evonik Health Care Recent Developments
  91. 7.16 Teva Active Pharmaceutical Ingredients
  92. 7.16.1 Teva Active Pharmaceutical Ingredients Company Information
  93. 7.16.2 Teva Active Pharmaceutical Ingredients Business Overview
  94. 7.16.3 Teva Active Pharmaceutical Ingredients Chemical API CDMO Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Teva Active Pharmaceutical Ingredients Chemical API CDMO Product Portfolio
  96. 7.16.5 Teva Active Pharmaceutical Ingredients Recent Developments
8 North America
  1. 8.1 North America Chemical API CDMO Revenue (2021-2032)
  2. 8.2 North America Chemical API CDMO Revenue by Type (2021-2032)
  3. 8.2.1 North America Chemical API CDMO Revenue by Type (2021-2026)
  4. 8.2.2 North America Chemical API CDMO Revenue by Type (2027-2032)
  5. 8.3 North America Chemical API CDMO Revenue Share by Type (2021-2032)
  6. 8.4 North America Chemical API CDMO Revenue by Application (2021-2032)
  7. 8.4.1 North America Chemical API CDMO Revenue by Application (2021-2026)
  8. 8.4.2 North America Chemical API CDMO Revenue by Application (2027-2032)
  9. 8.5 North America Chemical API CDMO Revenue Share by Application (2021-2032)
  10. 8.6 North America Chemical API CDMO Revenue by Country
  11. 8.6.1 North America Chemical API CDMO Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Chemical API CDMO Revenue by Country (2021-2026)
  13. 8.6.3 North America Chemical API CDMO Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Chemical API CDMO Revenue (2021-2032)
  2. 9.2 Europe Chemical API CDMO Revenue by Type (2021-2032)
  3. 9.2.1 Europe Chemical API CDMO Revenue by Type (2021-2026)
  4. 9.2.2 Europe Chemical API CDMO Revenue by Type (2027-2032)
  5. 9.3 Europe Chemical API CDMO Revenue Share by Type (2021-2032)
  6. 9.4 Europe Chemical API CDMO Revenue by Application (2021-2032)
  7. 9.4.1 Europe Chemical API CDMO Revenue by Application (2021-2026)
  8. 9.4.2 Europe Chemical API CDMO Revenue by Application (2027-2032)
  9. 9.5 Europe Chemical API CDMO Revenue Share by Application (2021-2032)
  10. 9.6 Europe Chemical API CDMO Revenue by Country
  11. 9.6.1 Europe Chemical API CDMO Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Chemical API CDMO Revenue by Country (2021-2026)
  13. 9.6.3 Europe Chemical API CDMO Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Chemical API CDMO Revenue (2021-2032)
  2. 10.2 China Chemical API CDMO Revenue by Type (2021-2032)
  3. 10.2.1 China Chemical API CDMO Revenue by Type (2021-2026)
  4. 10.2.2 China Chemical API CDMO Revenue by Type (2027-2032)
  5. 10.3 China Chemical API CDMO Revenue Share by Type (2021-2032)
  6. 10.4 China Chemical API CDMO Revenue by Application (2021-2032)
  7. 10.4.1 China Chemical API CDMO Revenue by Application (2021-2026)
  8. 10.4.2 China Chemical API CDMO Revenue by Application (2027-2032)
  9. 10.5 China Chemical API CDMO Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chemical API CDMO Revenue (2021-2032)
  2. 11.2 Asia Chemical API CDMO Revenue by Type (2021-2032)
  3. 11.2.1 Asia Chemical API CDMO Revenue by Type (2021-2026)
  4. 11.2.2 Asia Chemical API CDMO Revenue by Type (2027-2032)
  5. 11.3 Asia Chemical API CDMO Revenue Share by Type (2021-2032)
  6. 11.4 Asia Chemical API CDMO Revenue by Application (2021-2032)
  7. 11.4.1 Asia Chemical API CDMO Revenue by Application (2021-2026)
  8. 11.4.2 Asia Chemical API CDMO Revenue by Application (2027-2032)
  9. 11.5 Asia Chemical API CDMO Revenue Share by Application (2021-2032)
  10. 11.6 Asia Chemical API CDMO Revenue by Country
  11. 11.6.1 Asia Chemical API CDMO Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Chemical API CDMO Revenue by Country (2021-2026)
  13. 11.6.3 Asia Chemical API CDMO Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chemical API CDMO Revenue (2021-2032)
  2. 12.2 SAMEA Chemical API CDMO Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Chemical API CDMO Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Chemical API CDMO Revenue by Type (2027-2032)
  5. 12.3 SAMEA Chemical API CDMO Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Chemical API CDMO Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Chemical API CDMO Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Chemical API CDMO Revenue by Application (2027-2032)
  9. 12.5 SAMEA Chemical API CDMO Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Chemical API CDMO Revenue by Country
  11. 12.6.1 SAMEA Chemical API CDMO Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Chemical API CDMO Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Chemical API CDMO Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst